Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 216,105 | 198,772 | 192,640 | 254,382 | 268,682 |
| Cost of Goods | 13,044 | 11,314 | 14,796 | 24,282 | 25,629 |
| Gross Profit | 203,061 | 187,458 | 177,844 | 230,100 | 243,053 |
| Operating Expenses | 354,273 | 228,432 | 192,592 | 224,053 | 201,517 |
| Operating Income | -151,168 | -40,660 | -13,952 | 6,329 | 42,165 |
| Other Income | 12,521 | 17,739 | 20,291 | 4,971 | 199 |
| Pre-tax Income | -138,647 | -22,921 | 6,339 | 11,300 | 42,364 |
| Income Tax | 81,827 | -4,021 | 3,830 | 5,025 | 9,212 |
| Net Income Continuous | -220,474 | -18,900 | 2,509 | 6,275 | 33,152 |
| Net Income | $-220,474 | $-18,900 | $2,509 | $6,275 | $33,152 |
| EPS Basic Total Ops | -3.74 | -0.33 | 0.04 | 0.11 | 0.60 |
| EPS Basic Continuous Ops | -3.74 | -0.33 | 0.04 | 0.11 | 0.60 |
| EPS Diluted Total Ops | -3.74 | -0.33 | 0.04 | 0.11 | 0.58 |
| EPS Diluted Continuous Ops | -3.74 | -0.33 | 0.04 | 0.11 | 0.58 |
| EPS Diluted Before Non-Recurring Items | -1.81 | -0.33 | 0.04 | 0.11 | 0.58 |
| EBITDA(a) | $-141,304 | $-37,855 | $-18,417 | $6,099 | $46,655 |